Corrine Savill Cullinan Oncology, Inc. (CGEM) insider trading activity
Corrine Savill is Chief Business Officer of Cullinan Oncology, Inc.. Currently has a direct ownership of 240,990 shares of CGEM, which is worth approximately $2.08 Million. The most recent transaction as insider was on Feb 19, 2025, when has been sold 37,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
241K
18.43%
3M change
18.43%
12M change
Total Value Held
$2.08 Million
Corrine Savill Transaction History
CS
Corrine Savill
Chief Business Officer
Cambridge, MA